Tuesday, November 13, 2012
Print Current Day:
|
|
SESSION 1 SCHEDULE | |
Tuesday
SESSION 1:
NEW TOPICS IN AORTIC ANEURYSM AND PERIPHERAL VASCULAR DISEASE MANAGEMENT
Moderators:Jacob Cynamon, MD / Gabriel Bartal, MD, FSIR, FCIRSE
|
|
x | |
9:50 AM - 10:00 AM | Welcome And Introduction |
Presenter(s):Jacob Cynamon, MD | |
10:00 AM - 10:10 AM | Imaging For EVAR And TAVR Planning |
Presenter(s):Barry Stein, MD, FSIR, FACR | |
10:10 AM - 10:20 AM | Percutaneous EVAR: The Future Is Here |
Presenter(s):Barry T. Katzen, MD | |
10:20 AM - 10:30 AM | Endospan And Other New Soon To Be Available “Percutaneous” EVAR Devices |
Presenter(s):Eli Atar, MD, FSIR | |
10:30 AM - 10:40 AM | Pararenal EVAR Technology: Best Suited For Interventional Radiologists In An IR Suite |
Presenter(s):Barry T. Katzen, MD | |
10:40 AM - 10:50 AM | Thoracic Stent Graft Overview: What Is New |
Presenter(s):Michael D. Dake, MD | |
10:50 AM - 11:00 AM | Percutaneous Aortic Valve Placement: Putting Together A Team For Success |
Presenter(s):Barry T. Katzen, MD | |
11:00 AM - 11:10 AM | SFA/Pop Devices: What Tools Must You Have To Succeed |
Presenter(s):Andrew S. Blum, MD | |
11:10 AM - 11:20 AM | SAFARI Technique For Difficult Cases: How I Do It |
Presenter(s):Kevin Herman, MD | |
11:20 AM - 11:25 AM | Long-Term Femoro-Popliteal Patency Is Best Achieved By Using . . . |
Presenter(s):Richard R. Saxon, MD | |
11:25 AM - 11:30 AM | Pedal Vessels Are No Longer Off Limits: Technique And Devices |
Presenter(s):Robert A. Lookstein, MD, FSIR, FAHA | |
11:30 AM - 11:40 AM | Percutaneous Management Of Popliteal Aneurysms: Indications And Technique |
Presenter(s):John H. Rundback, MD, FSIR, FAHA | |
11:40 AM - 11:50 AM | Renal Denervation Is The Future Of IR Renal Intervention |
Presenter(s):Mark H. Wholey, MD | |
11:50 AM - 0:00 AM | Renal Angioplasty/Stenting Remains An Important Tool For The Treatment Of Renal Vascular Disease |
Presenter(s):Thomas A. Sos, MD | |
12:00 PM - 12:20 PM | Panel Discussion |
12:20 PM - 1:00 PM | Lunch On Your Own |
END OF SESSION 1 | |
SESSION 2 SCHEDULE | |
Tuesday
SESSION 2:
PROSTATIC ARTERY EMBOLIZATION (PAE) FOR BENIGN PROSTATIC HYPERTROPHY (BPH): A STEP-BY-STEP PRIMER
Moderators:Jacob Cynamon, MD / Daniel Y. Sze, MD, PhD
|
|
x | |
LOCATION: REGENT PARLOR, 2ND FLOOR | |
12:20 PM - 1:00 PM | Prostatic Artery Embolization (PAE) For Benign Prostatic Hypertrophy (BPH): A Step-By-Step Primer |
Presenter(s):Francisco C. Carnevale, MD, PhD | |
END OF SESSION 2 | |
SESSION 3 SCHEDULE | |
x | |
1:00 PM - 1:10 PM | DVT: Indications For IR Intervention |
Presenter(s):Daniel Y. Sze, MD, PhD | |
1:10 PM - 1:20 PM | DVT Lysis Techniques, Same Day vs. Overnight, Pros And Cons |
Presenter(s):Jacob Cynamon, MD | |
1:20 PM - 1:30 PM | ATTRACT Study Design: What We Expect To Learn And Why It Has Been So Difficult To Enroll |
Presenter(s):John H. Rundback, MD, FSIR, FAHA | |
1:30 PM - 1:40 PM | Iliac Stents Must Be Placed Using IVUS: Technique And Results |
Presenter(s):Seshadri Raju, MD | |
View Abstract | |
1:40 PM - 1:50 PM | Iliac Stents Can Be Placed Accurately Using Fluoroscopy: Technique And Results |
Presenter(s):Daniel Y. Sze, MD, PhD | |
1:50 PM - 2:00 PM | Refractory Femoral Vein Lesions: Management And Outcomes |
Presenter(s):Thomas O. McNamara, MD | |
2:00 PM - 2:10 PM | SVC Syndrome: Crossing The Impossible Occlusion Safely, Value Of The RF Wire |
Presenter(s):Neil J. Halin, DO | |
2:10 PM - 2:20 PM | Massive And Submassive PE: Is Intravenous Therapy Sufficient Or Is Intervention Indicated? |
Presenter(s):Piotr Sobieszczyk, MD | |
2:20 PM - 2:30 PM | Single Center Experience Using EKOS For Massive And Submassive PE And The Rationale And Design Of The SEATTLE II Trial |
Presenter(s):Robert J. Kennedy, MD | |
View Abstract | |
2:30 PM - 2:40 PM | IVC Filters: Self Regulation vs. Government Mandate |
Presenter(s):Matthew S. Johnson, MD | |
2:40 PM - 2:50 PM | Lessons Learned In Filter Retrieval |
Presenter(s):David W. Trost, MD | |
2:50 PM - 3:10 PM | Panel Discussion |
3:10 PM - 3:30 PM | Break |
END OF SESSION 3 | |
SESSION 4 SCHEDULE | |
Tuesday
SESSION 4:
VENOUS ABLATION: NEW TECHNIQUES, INDICATIONS AND DEVICES
Moderators:David Sperling, MD, FSIR / Robert I. White, Jr., MD, FSIR
|
|
x | |
3:30 PM - 3:40 PM | Varicose Vein Ablation: Review Of The Available Technologies |
Presenter(s):F. Scott Nowakowski, MD | |
3:40 PM - 3:50 PM | Developing A Varicose Vein Management Practice: How To Succeed In The Current And Future Reimbursement Climate |
Presenter(s):Richard A. Baum, MD, MPA, MBA | |
3:50 PM - 4:00 PM | Improved Techniques For Delivering Tumescent Anesthesia And A New Technique That May Eliminate The Need Of Tumescent Anesthesia |
Presenter(s):Rodney A. Raabe, MD | |
4:00 PM - 4:10 PM | Avoiding And Managing Complications Of Varicose Vein Ablations |
Presenter(s):Lowell S. Kabnick, MD, FACS, FACPh | |
4:10 PM - 4:20 PM | Management Of Superficial Veins Without Saphenous Vein Ablation: When And How |
Presenter(s):Israel Schur, MD | |
4:20 PM - 4:30 PM | Performing Microphlebectomy: Technique, Tools And Avoiding Complications |
Presenter(s):Jose I. Almeida, MD, FACS, RVT | |
4:30 PM - 4:40 PM | When And How Should The Gonadal Veins Or Iliac Veins Be Evaluated And Treated In Patients With Varicose Veins |
Presenter(s):Israel Schur, MD | |
4:40 PM - 4:50 PM | Varicocele Embolization In The Pediatric Patient: Is It An Underutilized Procedure |
Presenter(s):Jeffrey S. Pollak, MD | |
4:50 PM - 5:10 PM | Panel Discussion |
END OF SESSION 4 | |
SESSION 5 SCHEDULE | |
Tuesday
SESSION 5:
MULTIPLE SCLEROSIS AND THE INTERVENTIONAL RADIOLOGIST
Moderators:Michael D. Dake, MD / David Sperling, MD, FSIR
|
|
x | |
5:10 PM - 5:20 PM | What You Need To Know About MS Before Treating CCSVI |
Presenter(s):Paolo Zamboni, MD | |
5:20 PM - 5:30 PM | CCSVI: Patient Selection, Technique And Results Of Percutaneous Intervention |
Presenter(s):Salvatore J.A. Sclafani, MD | |
5:30 PM - 5:40 PM | CCSVI: Is IVUS Necessary Or Is Angiography And Pressure Measurements Sufficient? |
Presenter(s):Salvatore J.A. Sclafani, MD | |
5:40 PM - 5:50 PM | Is CCSVI A Real Disorder And Is Its Treatment Without Risk (Discussion) |
5:50 PM - 6:00 PM | Panel Discussion |
6:00 PM - 6:00 PM | Adjourn |
END OF SESSION 5 |